Loading…
1‑Deoxynojirimycin Derivative Containing Tegafur Induced HCT-116 Cell Apoptosis through Mitochondrial Dysfunction and Oxidative Stress Pathway
Three 1-deoxynojirimycin (DNJ) derivatives (named C4–C6) including DNJ and tegafur (TGF) were designed and synthesized, and their antiproliferative effects were investigated. C4–C6, especially C6, exerted good lipophilicity, α-glucosidase inhibitory activity, and antitumor effects. Mechanism studies...
Saved in:
Published in: | ACS medicinal chemistry letters 2024-11, Vol.15 (11), p.1947-1952 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Three 1-deoxynojirimycin (DNJ) derivatives (named C4–C6) including DNJ and tegafur (TGF) were designed and synthesized, and their antiproliferative effects were investigated. C4–C6, especially C6, exerted good lipophilicity, α-glucosidase inhibitory activity, and antitumor effects. Mechanism studies indicated that C6 significantly induced cell apoptosis and S-phase block and inhibited migration of HCT-116 cells. Besides, C6 induced mitochondrial damage by decreasing the mitochondrial membrane potential, improving the accumulation of ROS, upregulating the expression of Bax, and downregulating Bcl-2. Moreover, C6 induced excessive production of ROS to trigger oxidative stress, resulting in an increase in the level of MDA and NO, a decrease in the content of GSH and SOD, and an overexpression of Nrf2. Furthermore, C6 induced DNA damage by down-regulating the expression of thymidylate synthase. These results indicated that C6 is a potential antitumor agent and kills HCT-116 cells through DNA damage, mitochondrial dysfunction, and oxidative stress. |
---|---|
ISSN: | 1948-5875 1948-5875 |
DOI: | 10.1021/acsmedchemlett.4c00389 |